Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisViral quasispecies evolutionA Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-EscapeMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsMutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.Deletion mutants of VPg reveal new cytopathology determinants in a picornavirus.Variable mutation rates as an adaptive strategy in replicator populations.Viral genome segmentation can result from a trade-off between genetic content and particle stability.Severe hindrance of viral infection propagation in spatially extended hosts.Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population.Evaluation of anti-HIV-1 mutagenic nucleoside analogues.Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virusTempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach.The Attenuation Phenotype of a Ribavirin-Resistant Porcine Reproductive and Respiratory Syndrome Virus Is Maintained during Sequential Passages in Pigs.Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space.5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.Concomitant lethal mutagenesis of human immunodeficiency virus type 1.Back to the future: revisiting HIV-1 lethal mutagenesis.Ribavirin can be mutagenic for arenaviruses.Pathways to extinction: beyond the error threshold.Favipiravir elicits antiviral mutagenesis during virus replication in vivo.Mutagenesis-mediated virus extinction: virus-dependent effect of viral load on sensitivity to lethal defection.Competition-colonization dynamics: An ecology approach to quasispecies dynamics and virulence evolution in RNA viruses.Lethal mutagenesis of an RNA plant virus via lethal defection.Quasispecies and Drug ResistanceViral Quasispecies and Lethal MutagenesisFrom Quasispecies Theory to Viral Quasispecies: How Complexity has Permeated VirologyContribution of a Multifunctional Polymerase Region of Foot-and-Mouth Disease Virus to Lethal Mutagenesis
P2860
Q21132564-F3B3E8DD-F954-4AA1-91EB-72871D2DAF40Q27013917-87D431A1-E484-42C3-B42B-DC9497B31230Q27664656-E3A30313-4B04-487D-A92B-5168B32D50E7Q28072953-C7E2AF2B-BA8E-4BAD-8A67-5D6CB06D831CQ28476736-11060091-FF07-4C65-B182-CB8315AE8FE1Q33576672-C426087D-B19F-4322-9903-57F38AE1D77CQ33588570-69E7A6A8-F80B-4FEB-9F72-4920A3577402Q33612170-DA59FD30-FFEE-486F-9631-8368F540F081Q33855631-6B83B759-AA14-4F30-B68B-192377ECE546Q34017582-6B14681D-775E-453E-9DA6-E71BD9596E8DQ34326649-DF9C8F71-FAAC-41A9-82B1-F3DF436EF635Q34801497-8FCEB386-D222-4923-B80C-ED820A83D912Q35131997-2882C323-AC7F-42E2-BE25-3803E5FFAD0CQ35229409-B51D7E19-3C99-418B-8AD1-20F1E60F3DCDQ36811916-2A0D9814-A3B7-40FA-887A-5461BB86CC47Q38064285-A122E42B-8911-4DF9-B09D-D9BF6B2DAEF4Q38961370-4DE47227-B8F4-482A-8BE0-5222ADF1C847Q39080441-7B3B1505-5C33-4838-9406-FDE58786489AQ39378134-F76CE5BE-5708-4382-A3F8-6B2A1C7412A7Q39511261-8EDC477C-9551-4855-AD07-3C00B35D36C8Q39544616-BA4D9258-DE60-4A45-AC7F-BAFBF19494E5Q40863517-436C5BC9-D6CE-407C-841B-D82BE95D68A8Q41693281-56204B8A-FB06-428C-A4D3-98097DD99E9EQ41896864-6EBAA5E7-0B2F-49FE-B520-9D8B132609E2Q42145287-0BEEB97E-30DB-4286-9028-C2D95FADCA96Q47549513-8A5806B6-D9C4-4A60-9333-8A25DF3504B3Q56957250-06907CB0-A295-4E5E-9719-FEC689377785Q56957297-FD0AB688-B112-4E28-8339-25FA9C7B2E9FQ56957412-10FE8786-818F-475C-A01B-63F166844DAAQ57469924-AB596B1C-5004-4670-B2E0-3CFF363ACB99
P2860
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@ast
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@en
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@nl
type
label
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@ast
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@en
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@nl
prefLabel
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@ast
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@en
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@nl
P2860
P50
P3181
P1433
P1476
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
@en
P2093
Rubén Agudo
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1000658
P407
P577
2009-11-13T00:00:00Z